Baliling, Jerlyn .
HRN: 13-48-95 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/28/2024
CEFUROXIME 500MG (TAB)
12/28/2024
01/04/2025
PO
500mg
BID
Post Cs
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes